Shares of Aurobindo Pharma Ltd. were trading with losses of over 2% on Monday, September 30, after the company said that the ...

In the U.K., a pharma-run watchdog has been issuing fines and levying suspensions. Could this help build public trust?

ARS TECHNICA' recently reported that the maker of a homeopathic nasal spray is refusing to recall its product after the Food and Drug Administration (FDA) found evidence of dangerous microbial ...

SIFI, a leading international ophthalmic company, announced that is has received a Notice of Allowance from the European ...

Despite Biocon's assurances that the findings would not impact its business, investor sentiment appeared cautious.

Pfizer withdraws OXBRYTA after post marketing studies showed that the risks of side effects were greater than the benefits.

Harris promises to restore abortion rights if she is elected president. Among other things, she says she will see to it that ...

Pfizer withdrew its pill for sickle cell disease amid heightened European scrutiny, triggered by death rates seen in clinical ...

Currently, the drug is only approved by the Food and Drug Administration (FDA) for the long-term treatment of obesity (with or without Type 2 diabetes) in children who are at least 12 years old.

Modalis Therapeutics Corporation (Tokyo Stock Exchange: 4883, CEO: Haru Morita), a leading company pioneering treatments for rare genetic diseases using its proprietary CRISPR-based epigenome editing ...

For cancer patients in Virginia, treatment options are growing. The state has two National Cancer Institute-designated ...

The Food and Drug Administration sends warning letters to entities under its jurisdiction as part of its enforcement activities. Some letters are not ...